Study of RNS60 on Post-operative Pain and Function in Patients Undergoing Knee Anterior Cruciate Reconstruction Surgery
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 04 Feb 2015
Price : $35 *
At a glance
- Drugs RNS 60 (Primary) ; RNS 60 (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Revalesio
- 01 Feb 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 25 Jul 2014 Planned primary completion date changed from 1 Feb 2014 to 1 May 2015 as reported by ClinicalTrials.gov.
- 25 Jul 2014 Planned initiation date changed from 1 Jan 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.